酚妥拉明治疗慢性肺源性心脏病的疗效观察

目的观察酚妥拉明对慢性肺源性心脏病的疗效。方法选取我院心血管内科在2012年1月至2013年4月期间的慢性肺源性心脏病患者172例，按照随机化原则分为观察和对照组。观察组则在对照组的基础上予以酚妥拉明处理，将两组的疗效对此。结果对照组的治疗总有效率76．7％；观察组的治疗总有效率90．7％，观察组优于对照组，两组差异具有统计学意义（P〈0．05）。结论对于慢性肺源性心脏病患者，在常规综合治疗基础上，予以酚妥拉明处理，能显著提高疗效，值得在临床心血管内科推行。

Efficacy of Phentolamine Treatment of Chronic Pulmonary Heart Disease

Objective To observe the efficacy of phentolamine on chronic pulmonary heart disease. Methods 172 patients with chronic pulmonary heart disease from January 2012 to April 2013 in cardiovascular internal medicine department of our hospital were selected and randomly divided into observation group and control group. On the basis of conventional treatment, the observation group received phentolamine. Result In control group, the total effective rate was 76.7%; the data in observation group was 90.7%, implying a better efficacy than control group, the differences have statistical significance （P〈0.05）. Conclusions Based on the conventional treatment, phentolamine can significantly improve the efficacy in treating chronic pulmonary heart disease.